OPRX logo

OPRX

OptimizeRx CorporationNASDAQHealthcare
$6.56+0.00%ClosedMarket Cap: $123.1M

As of 2026-04-06

Valuation

View Details

P/E (TTM)

23.98

PEG

0.19

P/B

0.99

P/S

1.17

EV/EBITDA

7.95

DCF Value

$-13.31

FCF Yield

14.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

63.3%

Operating Margin

11.0%

Net Margin

4.7%

ROE

4.2%

ROA

2.9%

ROIC

5.6%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$32.2M$5.0M$0.26
FY 2025$109.4M$5.1M$0.27
Q3 2025$26.1M$779.0K$0.04
Q2 2025$29.2M$1.5M$0.08

Analyst Ratings

View All
B. Riley SecuritiesBuy
2026-03-06
Roth CapitalBuy
2026-03-06
StifelBuy
2026-03-06
Stephens & Co.Equal Weight
2026-03-06
Lake StreetBuy
2026-03-06

Trading Activity

Insider Trades

View All
Odence-Ford Marionofficer: Chief Legal & Admin Officer
SellFri Feb 13
Odence-Ford Marionofficer: Chief Legal & Admin Officer
SellFri Feb 13
Greco Theresaofficer: Chief Commercial Officer
SellTue Dec 23
Silvestro Stephen Lofficer: Chief Executive Officer
SellTue Dec 23
Odence-Ford Marionofficer: Chief Legal & Admin Officer
SellTue Dec 23

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NASDAQ

Beta

1.28

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

Peers